Skip to Main content Skip to Navigation
Journal articles

Recent Advances in Pain Management: Relevant Protein Kinases and Their Inhibitors

Abstract : The purpose of this review is to underline the protein kinases that have been established, either in fundamental approach or clinical trials, as potential biological targets in pain management. Protein kinases are presented according to their group in the human kinome: TK (Trk, RET, EGFR, JAK, VEGFR, SFK, BCR–Abl), CMGC (p38 MAPK, MEK, ERK, JNK, ASK1, CDK, CLK2, DYRK1A, GSK3, CK2), AGC (PKA, PKB, PKC, PKMζ, PKG, ROCK), CAMK, CK1 and atypical/other protein kinases (IKK, mTOR). Examples of small molecule inhibitors of these biological targets, demonstrating an analgesic effect, are described. Altogether, this review demonstrates the fundamental role that protein kinase inhibitors could play in the development of new pain treatments.
Document type :
Journal articles
Complete list of metadata
Contributor : Stéphanie Bonnefoy Connect in order to contact the contributor
Submitted on : Wednesday, May 26, 2021 - 4:07:28 PM
Last modification on : Sunday, June 26, 2022 - 3:08:46 AM
Long-term archiving on: : Friday, August 27, 2021 - 8:19:21 PM


Publication funded by an institution


Distributed under a Creative Commons Attribution 4.0 International License



Francis Giraud, Elisabeth Pereira, Fabrice Anizon, Pascale Moreau. Recent Advances in Pain Management: Relevant Protein Kinases and Their Inhibitors. Molecules, MDPI, 2021, 26 (9), pp.2696. ⟨10.3390/molecules26092696⟩. ⟨hal-03219644⟩



Record views


Files downloads